Project Grant HT94252310941
Award Date 8/15/23
Completion Date 8/14/26
Dollars Obligated $701K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19111, USA
Similar Awards
- The U.S. Defense Health Agency awarded a $1,880,000 Project Grant to The Institute for Cancer Research, a non-profit subsidiary of Temple University, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project to study the SRPK1-AKT signaling axis in endometrial cancer. As a prime grantee, The Institute for Cancer Research will conduct preclinical testing and analysis to develop new approaches for cancer prevention and...
- The Institute For Cancer Research, a non-profit research organization and subsidiary of Temple University, was awarded a $534,445 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate NETRIN G1 ligand as a new immunomodulatory target and early biomarker in pancreatic cancer, with a project period from August 1, 2023 to July 31, 2026. The Institute For Cancer Research has extensive...
- This $188,000 Project Grant was awarded on April 1, 2024 by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to The Institute For Cancer Research. The grant funds a research project titled "P2X7 RECEPTOR AS A NOVEL THERAPEUTIC TARGET IN PROSTATE CANCER" that will be conducted from April 1, 2024 through March 31, 2026. The Institute For Cancer Research, a non-profit subsidiary of Temple University, will carry out biomedical research...
- This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
- The federal Project Grant award for "TARGETING P2X7 RECEPTOR IN RENAL CELL CARCINOMA", totaling $1,269,000.00, was awarded to The Institute For Cancer Research, a non-profit subsidiary of Temple University, by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports biomedical research focused on developing new treatments for kidney cancer, a key health concern for military service members and veterans. The Institute For...
- The Defense Health Agency awarded a $634,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to Temple University. The grant, titled "Cellular and Molecular Heterogeneity in Esophageal Epithelium as a Contributor to Racial Disparities in Esophageal Cancer," will support research focused on addressing racial disparities in esophageal cancer from September 2024 to September 2026. As a prominent public research university, Temple...
- The federal Project Grant award with ID HT94252410970 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $188,000.00 award, issued on November 1, 2024, is funding research by the Institute for Cancer Research, a non-profit subsidiary of Temple University, to repair NF2 mutations using prime editing technology. The Institute for Cancer Research, based in Cheltenham, Pennsylvania, is a specialized research organization focused...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,128,000 Project Grant to The Institute For Cancer Research to conduct research on "Restoring PALB2 Function as a Mechanism of PARP1 Resistance in BRCA1-Mutant EOC". The award, with a performance period from July 1, 2024 to June 30, 2028, supports innovative scientific research aimed at improving health outcomes for military service members, veterans, and the broader...
- This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
- The Defense Health Agency has awarded a $4,954,747 Project Grant to the Dana-Farber Cancer Institute, Inc. (doing business as Dfci) to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "Novel Immunologic Discovery Platforms to Prevent Metastasis and Recurrence in Breast Cancer," will fund a four-year research project focused on developing new immunology-based approaches to prevent the spread and return of breast cancer. As a...